======= STRADB ======= == Gene Information == * **Official Symbol**: STRADB * **Official Name**: STE20 related adaptor beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55437|55437]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9C0K7|Q9C0K7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=STRADB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STRADB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607333|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that belongs to the serine/threonine protein kinase STE20 subfamily. One of the active site residues in the protein kinase domain of this protein is altered, and it is thus a pseudokinase. This protein is a component of a complex involved in the activation of serine/threonine kinase 11, a master kinase that regulates cell polarity and energy-generating metabolism. This complex regulates the relocation of this kinase from the nucleus to the cytoplasm, and it is essential for G1 cell cycle arrest mediated by this kinase. The protein encoded by this gene can also interact with the X chromosome-linked inhibitor of apoptosis protein, and this interaction enhances the anti-apoptotic activity of this protein via the JNK1 signal transduction pathway. Two pseudogenes, located on chromosomes 1 and 7, have been found for this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]. * **UniProt Summary**: Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation (By similarity). {ECO:0000250, ECO:0000269|PubMed:14517248}. |Pkinase Tyr| |Pkinase| |negative regulation of signal transduction in absence of ligand| |negative regulation of extrinsic apoptotic signaling pathway in absence of ligand| |aggresome| |regulation of extrinsic apoptotic signaling pathway in absence of ligand| |negative regulation of extrinsic apoptotic signaling pathway| |stress-activated protein kinase signaling cascade| |cell cycle arrest| |protein export from nucleus| |regulation of extrinsic apoptotic signaling pathway| |nuclear export| |negative regulation of apoptotic signaling pathway| |protein kinase activity| |nucleocytoplasmic transport| |nuclear transport| |activation of protein kinase activity| |protein serine/threonine kinase activity| |MAPK cascade| |signal transduction by protein phosphorylation| |regulation of apoptotic signaling pathway| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |cell part morphogenesis| |positive regulation of protein kinase activity| |negative regulation of cell cycle| |positive regulation of kinase activity| |positive regulation of transferase activity| |neuron projection development| |cell morphogenesis| |regulation of protein kinase activity| |neuron development| |cellular component morphogenesis| |regulation of kinase activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |protein phosphorylation| |regulation of transferase activity| |negative regulation of cell death| |intracellular protein transport| |cell cycle process| |neuron differentiation| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |plasma membrane bounded cell projection organization| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |cell projection organization| |regulation of cell cycle| |positive regulation of protein modification process| |negative regulation of signal transduction| |phosphorylation| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |ATP binding| |protein transport| |intracellular transport| |generation of neurons| |peptide transport| |regulation of apoptotic process| |regulation of programmed cell death| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |negative regulation of response to stimulus| |neurogenesis| |cell development| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |establishment of localization in cell| |regulation of protein modification process| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp256|HMS-I1 10μM R06 exp256]]|1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14898 * **Expression level (log2 read counts)**: 2.74 {{:chemogenomics:nalm6 dist.png?nolink |}}